Chinese company obtained the first patent of Corona virus vaccine

Spread the love

China has approved the patent of Corona Virus Vaccine of the Canadian Company. CanSino Biologics Inc has become the first Chinese company to receive a patent for the Corona virus vaccine. Reuters has quoted local media as saying that the casino has developed a vaccine named Ad5-nCOV.

According to a report by People’s Daily, China’s National Intellectual Property Administration approved the patent of the vaccine to CanSino Biologics Inc on August 11.

Earlier, Saudi Arabia had said that it was going to start phase-3 trial of Corona virus vaccine of the company. Cancino also talked about starting phase-3 trials in Russia, Brazil, Chile.

After the news came out, Hong Kong saw a 14 percent jump in the share price of the Cancino Company on Monday. At the same time, the company’s stock saw an increase of 6.6 percent in Shanghai.

Let us know that the vaccine candidate of Cancino has been prepared by making changes in the common cold virus. The Oxford University vaccine has also been prepared on this method. No side effects of this vaccine were revealed during the initial trial and the vaccine was able to produce antibodies and T cells.

Leave a Reply

Your email address will not be published. Required fields are marked *